Agios Pharmaceuticals Inc. Insider Trading

AGIO

Last 12 months

Insiders sold $4.98M and bought nothing on the open market.

97% of the selling was scheduled in advance under 10b5-1 plans. Principal Accounting Officer Theodore James Washburn Jr. sold 152K on Mar 3, 86% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2019.

Net open-market

−$4.98M

0 buys · 26 sales

Under a 10b5-1 plan

97%

of the value sold

Insiders who bought / sold

0 / 8

executives and directors

Last open-market buy

Nov 2019

Nov 13, 2019

Get an email when AGIO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 26	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	7,866	$37.69	296K	13%	Form 4
Oct 21 – 22	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan 2 parts	1,989	$37.53 average	75K	3.5%	Form 4
Aug 4	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	30,000	$30.48	914K	35%	Form 4
Jul 1	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	4,007	$37.56	151K	4.5%	Form 4
Apr 2	James William Burns Chief Legal Officer	Sold10b5-1 plan	3,280	$34.71	114K	6.2%	Form 4
Apr 2	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	2,940	$34.71	102K	3.5%	Form 4
Apr 2	Cecilia Jones Chief Financial Officer	Sold10b5-1 plan	3,141	$34.71	109K	5.4%	Form 4
Apr 2	Tsveta Milanova Chief Commercial Officer	Sold10b5-1 plan	3,262	$34.71	113K	6.5%	Form 4
Apr 2	Krishnan Viswanadhan Chief Corp Dev & Strategy	Sold10b5-1 plan	2,959	$34.71	103K	22%	Form 4
Apr 2	Brian Goff Chief Executive Officer	Sold10b5-1 plan 2 parts	19,068	$34.71 average	662K	9.4%	Form 4
Mar 5	Krishnan Viswanadhan Chief Corp Dev & Strategy	Sold10b5-1 plan	2,959	$27.80	82K	37%	Form 4
Mar 3	Theodore James Washburn Jr. Principal Accounting Officer	SoldNo plan	5,272	$28.88	152K	86%	Form 4
Mar 2	Brian Goff Chief Executive Officer	Sold10b5-1 plan 3 parts	18,055	$28.96 average	523K	9.9%	Form 4
Mar 2	James William Burns Chief Legal Officer	Sold10b5-1 plan 4 parts	5,218	$28.96 average	151K	11%	Form 4
Mar 2	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan 3 parts	4,055	$28.96 average	117K	5.2%	Form 4
Mar 2	Cecilia Jones Chief Financial Officer	Sold10b5-1 plan 4 parts	5,035	$28.96 average	146K	9.3%	Form 4
Mar 2	Tsveta Milanova Chief Commercial Officer	Sold10b5-1 plan 2 parts	2,868	$28.96 average	83K	6.5%	Form 4
Mar 2	Theodore James Washburn Jr. Principal Accounting Officer	Sold10b5-1 plan 3 parts	2,223	$28.96 average	64K	27%	Form 4
Jan 5	Tsveta Milanova Chief Commercial Officer	Sold10b5-1 plan	2,872	$27.02	78K	7.6%	Form 4
Dec 30, 2025	James William Burns Chief Legal Officer	Sold10b5-1 plan	2,932	$27.09	79K	8.5%	Form 4
Dec 30, 2025	Brian Goff Chief Executive Officer	Sold10b5-1 plan 2 parts	18,703	$27.09 average	507K	12%	Form 4
Dec 30, 2025	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	2,932	$27.09	79K	4.3%	Form 4
Dec 30, 2025	Tsveta Milanova Chief Commercial Officer	Sold10b5-1 plan	2,932	$27.09	79K	9.1%	Form 4
Dec 30, 2025	Cecilia Jones Chief Financial Officer	Sold10b5-1 plan	2,932	$27.09	79K	7.3%	Form 4
Nov 12, 2025	David Scadden Director	Sold10b5-1 plan	200	$43.84	9K	1.1%	Form 4
Nov 11, 2025	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	2,454	$43.78	107K	3.8%	Form 4
Oct 30, 2025	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	200	$43.81	9K	0.3%	Form 4
Oct 27, 2025	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	3,302	$43.92	145K	5.1%	Form 4
Oct 8, 2025	David Scadden Director	Sold10b5-1 plan	200	$41.00	8K	1.1%	Form 4
Sep 30, 2025	David Scadden Director	Sold10b5-1 plan	200	$40.00	8K	1.1%	Form 4
Sep 26, 2025	Cecilia Jones Chief Financial Officer	Sold10b5-1 plan	3,651	$36.77	134K	9.7%	Form 4
Sep 5, 2025	Theodore James Washburn Jr. Principal Accounting Officer	SoldNo plan	8,546	$36.87	315K	91%	Form 4
Aug 27, 2025	David Scadden Director	Sold10b5-1 plan	200	$40.00	8K	1.1%	Form 4
Aug 8, 2025	Brian Goff Chief Executive Officer	Sold10b5-1 plan	11,085	$36.67	406K	8.2%	Form 4
Jul 10, 2025	David Scadden Director	Sold10b5-1 plan	1,400	$40.00	56K	7.4%	Form 4
Jul 9, 2025	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan 2 parts	11,914	$37.99 average	453K	16%	Form 4
Jul 1, 2025	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	4,091	$34.17	140K	6.3%	Form 4
Jun 24, 2025	James William Burns Chief Legal Officer	Sold10b5-1 plan	2,799	$33.54	94K	8.9%	Form 4
Jun 24, 2025	Sarah Gheuens Chief Medical Officer	Sold10b5-1 plan	2,909	$33.54	98K	4.9%	Form 4
Jun 24, 2025	Cecilia Jones Chief Financial Officer	Sold10b5-1 plan	1,780	$33.54	60K	5.6%	Form 4

Oct 2610b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 7,866 at $37.69
296K
13% of stake
Oct 21 – 2210b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 1,989 at avg $37.53
75K
3.5% of stake
Aug 410b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 30,000 at $30.48
914K
35% of stake
Jul 110b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 4,007 at $37.56
151K
4.5% of stake
Apr 210b5-1 plan
James William Burns
Chief Legal Officer · sold 3,280 at $34.71
114K
6.2% of stake
Apr 210b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 2,940 at $34.71
102K
3.5% of stake
Apr 210b5-1 plan
Cecilia Jones
Chief Financial Officer · sold 3,141 at $34.71
109K
5.4% of stake
Apr 210b5-1 plan
Tsveta Milanova
Chief Commercial Officer · sold 3,262 at $34.71
113K
6.5% of stake
Apr 210b5-1 plan
Krishnan Viswanadhan
Chief Corp Dev & Strategy · sold 2,959 at $34.71
103K
22% of stake
Apr 210b5-1 plan
Brian Goff
Chief Executive Officer · sold 19,068 at avg $34.71
662K
9.4% of stake
Mar 510b5-1 plan
Krishnan Viswanadhan
Chief Corp Dev & Strategy · sold 2,959 at $27.80
82K
37% of stake
Mar 3No plan
Theodore James Washburn Jr.
Principal Accounting Officer · sold 5,272 at $28.88
152K
86% of stake
Mar 210b5-1 plan
Brian Goff
Chief Executive Officer · sold 18,055 at avg $28.96
523K
9.9% of stake
Mar 210b5-1 plan
James William Burns
Chief Legal Officer · sold 5,218 at avg $28.96
151K
11% of stake
Mar 210b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 4,055 at avg $28.96
117K
5.2% of stake
Mar 210b5-1 plan
Cecilia Jones
Chief Financial Officer · sold 5,035 at avg $28.96
146K
9.3% of stake
Mar 210b5-1 plan
Tsveta Milanova
Chief Commercial Officer · sold 2,868 at avg $28.96
83K
6.5% of stake
Mar 210b5-1 plan
Theodore James Washburn Jr.
Principal Accounting Officer · sold 2,223 at avg $28.96
64K
27% of stake
Jan 510b5-1 plan
Tsveta Milanova
Chief Commercial Officer · sold 2,872 at $27.02
78K
7.6% of stake
Dec 30, 202510b5-1 plan
James William Burns
Chief Legal Officer · sold 2,932 at $27.09
79K
8.5% of stake
Dec 30, 202510b5-1 plan
Brian Goff
Chief Executive Officer · sold 18,703 at avg $27.09
507K
12% of stake
Dec 30, 202510b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 2,932 at $27.09
79K
4.3% of stake
Dec 30, 202510b5-1 plan
Tsveta Milanova
Chief Commercial Officer · sold 2,932 at $27.09
79K
9.1% of stake
Dec 30, 202510b5-1 plan
Cecilia Jones
Chief Financial Officer · sold 2,932 at $27.09
79K
7.3% of stake
Nov 12, 202510b5-1 plan
David Scadden
Director · sold 200 at $43.84
9K
1.1% of stake
Nov 11, 202510b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 2,454 at $43.78
107K
3.8% of stake
Oct 30, 202510b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 200 at $43.81
9K
0.3% of stake
Oct 27, 202510b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 3,302 at $43.92
145K
5.1% of stake
Oct 8, 202510b5-1 plan
David Scadden
Director · sold 200 at $41.00
8K
1.1% of stake
Sep 30, 202510b5-1 plan
David Scadden
Director · sold 200 at $40.00
8K
1.1% of stake
Sep 26, 202510b5-1 plan
Cecilia Jones
Chief Financial Officer · sold 3,651 at $36.77
134K
9.7% of stake
Sep 5, 2025No plan
Theodore James Washburn Jr.
Principal Accounting Officer · sold 8,546 at $36.87
315K
91% of stake
Aug 27, 202510b5-1 plan
David Scadden
Director · sold 200 at $40.00
8K
1.1% of stake
Aug 8, 202510b5-1 plan
Brian Goff
Chief Executive Officer · sold 11,085 at $36.67
406K
8.2% of stake
Jul 10, 202510b5-1 plan
David Scadden
Director · sold 1,400 at $40.00
56K
7.4% of stake
Jul 9, 202510b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 11,914 at avg $37.99
453K
16% of stake
Jul 1, 202510b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 4,091 at $34.17
140K
6.3% of stake
Jun 24, 202510b5-1 plan
James William Burns
Chief Legal Officer · sold 2,799 at $33.54
94K
8.9% of stake
Jun 24, 202510b5-1 plan
Sarah Gheuens
Chief Medical Officer · sold 2,909 at $33.54
98K
4.9% of stake
Jun 24, 202510b5-1 plan
Cecilia Jones
Chief Financial Officer · sold 1,780 at $33.54
60K
5.6% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AGIO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with AGIO

CompareIntrinsic value

SPRYArs Pharmaceuticals Inc

$3.05+0.00%40

XNCRXencor Inc.

$35.01+14.28%0

ASRTAssertio Holdings Inc.

$9.09+0.28%10

SIGASiga Technologies Inc.

$3.15+1.29%20

CYTKCytokinetics, Incorporated

$63.60+2.07%10

ARVNArvinas Inc.

$7.42+4.65%40

ETONEton Pharmaceuticals Inc.

$50.72-0.45%75

TBPHTheravance Biopharma Inc.

No recent price82

Held by ETFs

AGIO is in 53 US ETFs. The largest of them, with AGIO's weight in each:

Spot a number that looks wrong? Check it in AGIO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AGIO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.